Bhagirath, D., et al. (2018). microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res 78(7): 1833-1844 10.1158/0008-5472.CAN-17-2069
Byun, Y., et al. (2001). Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 8(5): 443-450 10.1038/sj.cdd.4400840
Cain, H., et al. (1983). Vimentin filaments in peritoneal macrophages at various stages of differentiation and with altered function. Virchows Arch B Cell Pathol Incl Mol Pathol 42(1): 65-81 10.1007/BF02890371
Chandrashekar, D. S., et al. (2017). UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia 19(8): 649-658 10.1016/j.neo.2017.05.002
Cheng, F., et al. (2016). Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-beta-Slug signaling. Proc Natl Acad Sci U S A 113(30): E4320-4327 10.1073/pnas.1519197113
Cong, H., et al. (2016). DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer. Oncol Lett 11(1): 842-848 10.3892/ol.2015.3937
Csak, T., et al. (2015). microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int 35(2): 532-541 10.1111/liv.12633
Eckes, B., et al. (1998). Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci 111 ( Pt 13): 1897-1907
Eriksson, J. E., et al. (2009). Introducing intermediate filaments: from discovery to disease. J Clin Invest 119(7): 1763-1771 10.1172/JCI38339
Fernandez-Ortega, C., et al. (2016). Identification of Vimentin as a Potential Therapeutic Target against HIV Infection. Viruses 8(6) 10.3390/v8060098
Franke, W. W., et al. (1978). Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci U S A 75(10): 5034-5038 10.1073/pnas.75.10.5034
Fuyuhiro, Y., et al. (2010). Clinical significance of vimentin-positive gastric cancer cells. Anticancer Res 30(12): 5239-5243
Gao, J., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269): pl1 10.1126/scisignal.2004088
Ghosh, P., et al. (2018). Invasion of the Brain by Listeria monocytogenes Is Mediated by InlF and Host Cell Vimentin. mBio 9(1) 10.1128/mBio.00160-18
Gilles, C., et al. (1999). Vimentin contributes to human mammary epithelial cell migration. J Cell Sci 112 ( Pt 24): 4615-4625
Helfand, B. T., et al. (2011). Vimentin organization modulates the formation of lamellipodia. Mol Biol Cell 22(8): 1274-1289 10.1091/mbc.E10-08-0699
Hsu, P. C., et al. (2014). Vimentin is involved in peptidylarginine deiminase 2-induced apoptosis of activated Jurkat cells. Mol Cells 37(5): 426-434 10.14348/molcells.2014.2359
Huang, Y., et al. (2015). miR-141 regulates TGF-beta1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells. Int J Mol Med 35(2): 311-318 10.3892/ijmm.2014.2008
Huber, M. A., et al. (2005). Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17(5): 548-558 10.1016/j.ceb.2005.08.001
Hugo, H., et al. (2007). Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression. J Cell Physiol 213(2): 374-383 10.1002/jcp.21223
Huo, Y., et al. (2016). Downregulation of vimentin expression increased drug resistance in ovarian cancer cells. Oncotarget 7(29): 45876-45888 10.18632/oncotarget.9970
Imamichi, Y. and A. Menke (2007). Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition. Cells Tissues Organs 185(1-3): 180-190 10.1159/000101319
Jin, H., et al. (2010). Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis. Biomed Res 31(2): 105-112 10.2220/biomedres.31.105
Kokkinos, M. I., et al. (2007). Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo. Cells Tissues Organs 185(1-3): 191-203 10.1159/000101320
Lavastre, V., et al. (2002). Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. J Immunol 168(3): 1419-1427 10.4049/jimmunol.168.3.1419
Lee, S. J., et al. (2014). The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis. BMB Rep 47(8): 457-462 10.5483/bmbrep.2014.47.8.256
Li, C. and J. F. Kuemmerle (2020). The fate of myofibroblasts during the development of fibrosis in Crohn's disease. J Dig Dis 21(6): 326-331 10.1111/1751-2980.12852
Li, K., et al. (2018). Identification of gene-specific DNA methylation signature for Colorectal Cancer. Cancer Genet 228-229: 5-11 10.1016/j.cancergen.2018.05.003
Li, Z., et al. (2020). Vimentin as a target for the treatment of COVID-19. BMJ Open Respir Res 7(1) 10.1136/bmjresp-2020-000623
Li, Z. M., et al. (2008). [Enhanced expression of human vimentin intermediate filaments in hepatocellular carcinoma cells decreases their proliferative and invasive abilities in vitro]. Zhonghua Zhong Liu Za Zhi 30(6): 408-412
Loberg, R. D., et al. (2005). Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype. J Clin Oncol 23(32): 8232-8241 10.1200/JCO.2005.03.0841
Lowery, J., et al. (2015). Intermediate Filaments Play a Pivotal Role in Regulating Cell Architecture and Function. J Biol Chem 290(28): 17145-17153 10.1074/jbc.R115.640359
McInroy, L. and A. Maatta (2007). Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 360(1): 109-114 10.1016/j.bbrc.2007.06.036
Mei, J. W., et al. (2019). MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1. BMC Cancer 19(1): 740 10.1186/s12885-019-5929-1
Meng, X., et al. (2011). Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition. PLoS One 6(4): e18715 10.1371/journal.pone.0018715
Menko, A. S., et al. (2014). A central role for vimentin in regulating repair function during healing of the lens epithelium. Mol Biol Cell 25(6): 776-790 10.1091/mbc.E12-12-0900
Moisan, E. and D. Girard (2006). Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukoc Biol 79(3): 489-498 10.1189/jlb.0405190
Morishima, N. (1999). Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action. Genes Cells 4(7): 401-414 10.1046/j.1365-2443.1999.00270.x
Patteson, A. E., et al. (2019). Loss of Vimentin Enhances Cell Motility through Small Confining Spaces. Small 15(50): e1903180 10.1002/smll.201903180
Perreau, J., et al. (1988). Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene 62(1): 7-16 10.1016/0378-1119(88)90575-6
Puche, J. E., et al. (2013). Hepatic stellate cells and liver fibrosis. Compr Physiol 3(4): 1473-1492 10.1002/cphy.c120035
Qureshi, R., et al. (2015). EMT in cervical cancer: its role in tumour progression and response to therapy. Cancer Lett 356(2 Pt B): 321-331 10.1016/j.canlet.2014.09.021
Rathje, L. S., et al. (2014). Oncogenes induce a vimentin filament collapse mediated by HDAC6 that is linked to cell stiffness. Proc Natl Acad Sci U S A 111(4): 1515-1520 10.1073/pnas.1300238111
Richardson, F., et al. (2012). The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy. Anticancer Res 32(2): 537-552
Rittling, S. R. and R. Baserga (1987). Functional analysis and growth factor regulation of the human vimentin promoter. Mol Cell Biol 7(11): 3908-3915 10.1128/mcb.7.11.3908
Shi, R., et al. (2014). Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism. Front Med 8(4): 456-463 10.1007/s11684-014-0353-z
Siegel, R. L., et al. (2021). Cancer Statistics, 2021. CA Cancer J Clin 71(1): 7-33 10.3322/caac.21654
Sommers, C. L., et al. (1989). Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. Cancer Res 49(15): 4258-4263
Su, L., et al. (2019). Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis. Sci Rep 9(1): 5747 10.1038/s41598-019-42287-7
Suprewicz, L., et al. (2021). Vimentin binds to SARS-CoV-2 spike protein and antibodies targeting extracellular vimentin block in vitro uptake of SARS-CoV-2 virus-like particles. bioRxiv 10.1101/2021.01.08.425793
Szklarczyk, D., et al. (2019). STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1): D607-D613 10.1093/nar/gky1131
Takemura, K., et al. (1994). Expression of vimentin in gastric cancer: a possible indicator for prognosis. Pathobiology 62(3): 149-154 10.1159/000163895
Tanaka, S., et al. (2015). Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells. Biol Pharm Bull 38(3): 435-440 10.1248/bpb.b14-00695
Uhlen, M., et al. (2015). Proteomics. Tissue-based map of the human proteome. Science 347(6220): 1260419 10.1126/science.1260419
Ulirsch, J., et al. (2013). Vimentin DNA methylation predicts survival in breast cancer. Breast Cancer Res Treat 137(2): 383-396 10.1007/s10549-012-2353-5
Warde-Farley, D., et al. (2010). The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38(Web Server issue): W214-220 10.1093/nar/gkq537
Xu, J., et al. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res 19(2): 156-172 10.1038/cr.2009.5
Yu, M. B., et al. (2018). Extracellular vimentin modulates human dendritic cell activation. Mol Immunol 104: 37-46 10.1016/j.molimm.2018.09.017
Yu, Y. T., et al. (2016). Surface vimentin is critical for the cell entry of SARS-CoV. J Biomed Sci 23: 14 10.1186/s12929-016-0234-7
Zhang, J., et al. (2016). MicroRNA-138 modulates metastasis and EMT in breast cancer cells by targeting vimentin. Biomed Pharmacother 77: 135-141 10.1016/j.biopha.2015.12.018
Zhang, Y., et al. (2020). The diverse roles and dynamic rearrangement of vimentin during viral infection. J Cell Sci 134(5) 10.1242/jcs.250597
Zhao, Y., et al. (2009). The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J Biol Chem 284(3): 1385-1393 10.1074/jbc.M802612200
Zhou, T., et al. (2019). Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2(-/-) mouse model of primary sclerosing cholangitis (PSC). EBioMedicine 48: 130-142 10.1016/j.ebiom.2019.09.013
Zhu, Y., et al. (2017). USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells. Oncotarget 8(30): 48725-48736 10.18632/oncotarget.10706
Zuberi, K., et al. (2013). GeneMANIA prediction server 2013 update. Nucleic Acids Res 41(Web Server issue): W115-122 10.1093/nar/gkt533